SulNOx Group PLC (AQU:SNOX)
London · Delayed Price · Currency is GBP · Price in GBX 53.50
0.00 (0.00%)
At close: Nov 12, 2025
SulNOx Group Revenue
In the fiscal year ending March 31, 2025, SulNOx Group had annual revenue of 1.12M GBP with 106.03% growth. SulNOx Group had revenue of 680.75K in the half year ending March 31, 2025, with 430.71% growth.
Revenue
1.12M
Revenue Growth
+106.03%
P/S Ratio
64.15
Revenue / Employee
124.56K
Employees
9
Market Cap
71.91M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.12M | 576.96K | 106.03% |
| Mar 31, 2024 | 544.12K | 341.04K | 167.94% |
| Mar 31, 2023 | 203.08K | 169.55K | 505.80% |
| Mar 31, 2022 | 33.52K | 15.63K | 87.32% |
| Mar 31, 2021 | 17.90K | -24.77K | -58.06% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| British American Tobacco p.l.c. | 25.60B |